Henry Ford Hospital Medical Journal
Volume 40, Number 3 (1992)
Articles
Proceedings of the Fourth International Workshop on Multiple Endocrine Neoplasia: Introduction
Robert F. Gagel and Charles E. Jackson
Sublocalization of the Multiple Endocrine Neoplasia Type 1 Gene
Catharina Larsson, Gunther Weber, and Marie Janson
Molecular Genetic Mapping of the Multiple Endocrine Neoplasia Type 1 Locus
Joanna T. Pang, Mark A. Pook, James H. Eubanks, Carol Jones, Veronica van Heyningen, Glen A. Evans, and Rajesh V. Thakker
Prospective Screening in Multiple Endocrine Neoplasia Type 1
Britt Skogseid and Kjell Oberg
The Importance of Screening for the MEN 1 Syndrome: Diagnostic Results and Clinical Management
C. J. M. Lips, H. P. F. Koppeschaar, M. J. H. Berends, J. M. Jansen-Schillhorn van Veen, A. Struyvenberg, and Th. J. M. V. Van Vroonhoven
Practical Guidelines for DNA-Based Testing in Multiple Endocrine Neoplasia Type 1
Catharina Larsson, Magnus Nordenskjold, Britt Skogseid, and Kjell Oberg
PRAD1 (Cyclin D1): A Parathyroid Neoplasia Gene on 11q13
Andrew Arnold, Toru Motokura, Theodora Bloom, Carol Rosenberg, Allen Bale, Henry Kronenberg, Joan Ruderman, Milton Brown, and Hyung Goo Kim
Parathyroid Tumor Biology in Familial Multiple Endocrine Neoplasia Type 1: A Model for Cancer Development
Maria Luisa Brandi
Hyperparathyroidism with Normal Albumin-Corrected Total Calcium in Patients with Multiple Endocrine Neoplasia Type 1
J. J. Shepherd, Bin Tean Teh, V. Parameswaran, and R. David
Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1: Experience by a Single Surgical Team in Japan
Takao Obara, Yoshihide Fujimoto, and Yukio Ito
Surgical Treatment of the Endocrine Pancreas and Zollinger-Ellison Syndrome in the MEN 1 Syndrome
Norman W. Thompson
Localization of the Gene for MEN 2A
Jay B. Lichter, Michael Difilippantonio, Jingshi Wu, Diane Miller, David C. Ward, Paul J. Goodfellow, and Kenneth K. Kidd
A Preliminary Analysis of Consortium Data for Markers Tightly Linked to Multiple Endocrine Neoplasia Type 2A
J. B. Lichter, S. M. Hackleman, B. A. J. Ponder, D. Easton, S. A. Narod, G. M. Lenoir, R. F. Gagel, N. E. Simpson, E. Gardner, P. J. Goodfellow, S. Takai, A. J. Pakstis, and K. K. Kidd
Isolation of YAC Clones From the Pericentromeric Region of Chromosome 10 and Development of New Genetic Markers Linked to the Multiple Endocrine Neoplasia Type 2A Gene
Terry C. Lairmore, James R. Howe, Shenshen Dou, Rosalie Veile, Jennifer A. Korte-Sarfaty, Samuel A. Wells Jr., and Helen Donis-Keller
Expression of the ret Proto-oncogene in Human Medullary Thyroid Carcinomas and Pheochromocytomas of MEN 2A
Akihiro Miya, Masayuki Yamamoto, Hideki Morimoto, Norifumi Tanaka, Esei Shin, Katsu Karakawa, Kumao Toyoshima, Yukihito Ishizaka, Takesada Mori, and Shin-Ichiro Takai
Medullary Thyroid Carcinoma: Australian Experience with Genetic Testing
Janet L. Ward, Valentine J. Hyland, David S. Andrew, Debbie J. Marsh, and Bruce G. Robinson
Screening for Multiple Endocrine Neoplasia Type 2A with DNA-Polymorphism Analysis
Estelle M.-F. Lamothe, Steven A. Narod, Shari Miller, Paul J. Goodfellow, David E. C. Cole, Dawna Gilchrist, Zdenka Pausova, David Goltzman, and Geoffrey N. Hendy
High-Sensitivity Serum Calcitonin Assays Applied to Screening for Thyroid C-Cell Disease in Multiple Endocrine Neoplasia Type 2A
Michael M. Kaplan, Glenn M. Stall, Timothy Cummings, Andrew MacAulay, Philippe Motté, Hubert J. Wolfe, Seymour Reichlin, and Arman J. Tashjian Jr.
Genetics of the Multiple Endocrine Neoplasia Type 2B Syndrome
Charles E. Jackson and Robert A. Norum
Multiple Endocrine Neoplasia Type 2B: Eighteen-Year Follow-up of a Four-Generation Family
Glen W. Sizemore, J. Aiden Carney, Hossein Gharib, and Charles C. Capen
Cutaneous Lesion Associated with Multiple Endocrine Neoplasia Type 2A: Lichen Amyloidosis or Notalgia Paresthetica?
O. Chabre, F. Labat, N. Pinel, F. Berthod, V. Tarel, and I. Bachelot
Characterization of the Clinical Features of Five Families with Hereditary Primary Cutaneous Lichen Amyloidosis and Multiple Endocrine Neoplasia Type 2
Marion F. Robinson, Eric J. Furst, Vincenzo Nunziata, Maria Luisa Brandi, Jorge P. Ferrer, Maria J. G. Martins Bugalho, Guiseppe di Giovanni, Richard J. H. Smith, Donald T. Donovan, Bobby R. Alford, James F. Hejtmancik, Vittorio Colantuoni, Loredana Quadro, Edward Limbert, Irene Halperin, Enric Vilardell, and Robert F. Gagel
Unusual Features of Multiple Endocrine Neoplasia
Andrea Frilling, Heinz Becker, and Hans-Dietrich Roeher
Long-term Follow-up in Four Large MEN 2 Families in The Netherlands
C. J. M. Lips, M. J. H. Berends, J. Brouwers-Smalbraak, R. A. Geerdink, W. H. L. Hackeng, J. M. Jansen-Schillhorn van Veen, A. Struyvenberg, and Th. J. M. V. van Vroonhoven
Mineral Metabolic Effects of Thyroidectomy and Long-term Outcomes in a Family with MEN 2A
Henry G. Bone III, Leonard J. Deftos, William H. Snyder, and Charles Y. C. Pak
Statistical Analysis of Histomorphological Findings in Medullary Thyroid Carcinoma: Distinction Between the Different Familial Forms of the Disease
B. Franc, M. Rosenberg-Bourgin, B. Auvert, B. Caillou, N. Dutrieux-Berger, J. Floquet, M. Houcke-Lecomte, E. Justrabo, F. Labat-Moleur, M. F. Le Bodic, A. Pages, M. Patey, G. Viennet, F. Vilde, and J. P. Saint-Andre
Frequency and Significance of Cervicomediastinal Lymph Node Metastases in Medullary Thyroid Carcinoma: Results of a Compartment-Oriented Microdissection Method
Henning Dralle, Iris Damme, Georg Friedrich Wilhelm Scheumann, Jorg Kotzerke, and Eckhart Kupsch
Microsurgical Lymph Node Dissection for Metastatic Asymptomatic C-Cell Carcinoma
Heinz J. Buhr, Friedrich Kallinowski, Friedhelm Raue, and Christian Herfarth
Should Patients with Medullary Thyroid Carcinoma Undergo Extensive Lymph Node (Re)Operation to Improve Long-term Survival?
Caro Brumsen, Harm R. Haak, Bernard M. Goslings, and Cornelis J. H. van de Velde
Pheochromocytoma: A Frequent Indicator for MEN 2
Claude Calmettes, Myriam Rosenberg-Gourgin, Jean Caron, and Nicole Feingold
Surgical Approach of Synchronous Medullary Thyroid Carcinoma and Pheochromocytoma in MEN 2 Syndrome
Georg F. W. Scheumann and Henning Dralle
Evaluation of Children with Medullary Thyroid Carcinoma
Alfonso Libroia, Fabrizio Muratori, Uberta Verga, Gianleone Di Sacco, Anna Grattieri, and Dario Gelli
Oncogene and Growth Factor Expression in MEN 2 and Related Tumors
Jeffrey F. Moley, Göran K. Wallin, Michele B. Brother, Michael Kim, Samuel A. Wells Jr., and Garrett M. Brodeur
Somatostatin Acts Via a Pertussis Toxin-Sensitive Mechanism on Calcitonin Secretion in C-Cells
Angela Zink, Hans Scherubl, Friedhelm Raue, and Reinhard Ziegler
Role of Insulin-Like Growth Factor-I in the Autocrine Regulation of Cell Growth in TT Human Medullary Thyroid Carcinoma Cells
Kuo-Pao P. Yang, Naguib A. Samaan, Yi-Fan Liang, and Socorro G. Castillo
PDN-21 (Katacalcin) and Chromogranin A: Tumor Markers for Medullary Thyroid Carcinoma
Friedhelm Raue, Eberhard Blind, and Andreas Grauer
Biologic and Cytogenetic Characterization of Three Human Medullary Thyroid Carcinomas in Culture
R. Pfragner, G. Wirnsberger, A. Behmel, B. Niederle, F. Längle, R. Roka, A. Mandl, P. Pürstner, J. Auner, and F. Tatzber
Extracellular Ca2+ Sensing in C-Cells and Parathyroid Cells
Hans Scherubl, Maria Luisa Brandi, and Jurgen Hescheler
Patterns of Neoplasia in c-Mos Transgenic Mice and Their Relevance to Multiple Endocrine Neoplasia
Nicholas Schulz, Friedrich Propst, Michael M. Rosenberg, R. Ilona Linnoila, Richard S. Paules, Douglas Schulte, and George F. Vande Woude
